Lymphedema in patients with X-linked severe combined immunodeficiency

Background: IL2RG and JAK3 mutations cause T-cell–negative, B-cell–positive, natural killer cell–negative severe combined immunodeficiency (SCID). Cell therapies such as hematopoietic stem cell transplantation (or gene therapy for IL2RG deficiency) can effectively restore T-cell immunity but—when pe...

Descripció completa

Dades bibliogràfiques

Autors principals:	Filippo Consonni, MD, Suk See De Ravin, MD, PhD, Stephane Vignes, MD, Virginie Courteille, PhD, Marina Cavazzana, MD, PhD, Laureline Berteloot, MD, PhD, Alain Fischer, MD, PhD, Bénédicte Neven, MD, PhD
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2026-01-01
Col·lecció:	Journal of Allergy and Clinical Immunology: Global
Matèries:	SCID pediatrics gamma chain innate lymphoid cells lymphedema hematopoietic stem cell transplantation
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2772829325001924
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!